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Abstract
Introduction and hypothesis A study was conducted to as-
sess associations between different overactive bladder
(OAB) symptoms and their outcomes on bladder diary and
filling cystometry parameters.
Methods We performed a retrospective cohort study in data-
base of 6,876 Urinary Distress Inventories, 3,185 bladder
diaries and 2,153 filling cystometries from women referred
to our urogynecological center between 2003 and 2009.Wom-
en were dichotomized into two groups. Group I: those women
without symptoms, and those with symptoms that were not
bothersome. Group II: women with bothersome symptoms.
Data obtained from bladder diaries were: daytime urinary
frequency, nocturnal frequency, minimum voided volume,
maximum voided volume, average voided volume, and in-
continence episodes. From filling cystometries, volumes at
first desire to void, normal desire to void, strong desire to void
and maximum cystometric capacity, were extracted. Univari-
ate and multiple linear regression analysis were performed to
determine associations between OAB symptoms and bladder
diary and filling cystometry measurements.
Results After multivariate analysis the objective daytime
frequency was most strongly associated with the frequency
symptom (β 0.27, p<0.05), night time frequency with the
nocturia symptom (β 0.40, p<0.05) and the number of
incontinence episodes with the urge incontinence symptom
(β 0.37, p<0.05). Both frequency and nocturia symptoms
were significantly associated with bladder diary and cyst-
ometry filling volumes, and their effect size was the same.
The urgency symptom proved to be poorly associated with
objective parameters.
Conclusions In contrast to the frequency and nocturia
symptom, the urgency symptom is poorly associated with
objective parameters on bladder diary and filling cystome-
try. Therefore, the current practice of using frequency and
incontinence episodes in outcome research of OAB trials is
justified.
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Introduction
The overactive bladder syndrome (OAB) represents a group
of prevalent micturition symptoms that are known to have a
negative impact on quality of life [1–3]. Population-based
studies on women report a prevalence of OAB that varies
between 9.7% and 35.7%, with a substantial rise in preva-
lence with increasing age [4, 5]. Approximately 50% of
women with OAB reported experiencing symptoms that
were bothersome in their daily life. The OAB syndrome is
internationally defined as: urinary urgency, usually accom-
panied by frequency and nocturia with or without urgency
urinary incontinence, in the absence of urinary tract infec-
tion or other obvious pathology [6]. This definition indicates
that the presence of urgency is mandatory in diagnosing
OAB. However, in research on the outcome of treatment
modalities for OAB, the primary outcome in the majority of
studies is the reduction in daily micturition and/or urinary
incontinence episodes. [7–10]. Apparently there is a dis-
crepancy between the importance of the urgency symptom
in making a diagnosis of OAB, and in the evaluation of
OAB treatment. This raises the question whether the sever-
ity of the urgency symptom is quantitatively associated with
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objective parameters as measured with a bladder diary and
filling cystometry.
The aim of our study is to assess the association between




A retrospective cohort study was performed with a database
containing 6,876 questionnaires that were completed by
women who were referred to our urogynecological center
between 2003 and 2009. From this database our final study
population comprised 3,280 women with 48-h bladder dia-
ries and 2,153 women with available information on filling
cystometries. This study was reviewed by our Medical Re-
search Ethics Committee (MREC), which concluded that no
Medical Research Involving Human Subjects Act (WMO)
approval was needed, since the study neither implied that
the women would receive a particular treatment, nor impact-
ed on the behavior of the women.
Measurements
As part of the routine work-up, all women filled out the
validated Dutch version of the Urinary Distress Inventory
(UDI) [11]. The original UDI consists of 19 items. Each
item measures if a micturition symptom is present and to
what extent the patient is bothered by this symptom. Bother
is measured on a four-point Likert scale ranging from not at
all to greatly bothered. For the purpose of this study we
selected four lower urinary tract symptoms (LUTS) from the
UDI that are in concordance with ICS definitions. LUTS
were assessed with the following questions: on frequency
“Do you experience frequent urination?”, on urgency “Do
you experience a strong feeling of urgency to empty your
bladder?”, on nocturia “Do you experience frequent urina-
tion at night?”, on urgency incontinence “Do you experi-
ence urine leakage related to a feeling of urgency?” [12].
We dichotomized the study population for every OAB
symptom into two groups. Group 1 consisted of women
without the symptom, or those with the symptom but with-
out any bother. Group 2 consisted of women who were
slightly, moderately or greatly bothered by one of the
symptoms.
Women were asked to complete a 24-h bladder diary
during a minimum of 2 days, prior to their consultation at
our center. From these dairies, time and volume (measured
with a measuring cup) of voiding episodes, as well as time
and amount of fluid intake were recorded. The frequency
and amount of incontinence were noted along with
complaints of pain, urgency, straining to void, and bandage
changes. From the bladder diaries we extracted the follow-
ing information: daytime urinary frequency, nocturnal fre-
quency, minimum voided volume, maximum voided
volume, mean voided volume, and incontinence episodes.
Filling cystometry (Medtronic Duet®; Medtronic, Min-
neapolis, MN, USA) was performed at an infusion rate of
50 mL/min. Bladder sensations during filling cystometry
were recorded, conforming to official ICS guidelines [6].
We did not collect all information about drug use, which
might influence bladder function. In case of performing
cystometry, all women stopped using anticholinergic drugs
for at least one week prior to the investigation. Finally, we
collected data on age and parity.
Statistical analysis
The frequencies of reported OAB symptoms, mean age, and
parity of women were assessed. A Student’s t test was used
to compare mean bladder diary and filling cystometry
parameters between groups. The chance of finding statisti-
cally, but not clinically significant differences increases with
a large study sample. In order to assess the strength of the
relationship, effect sizes (Cohen’s d) were calculated for all
statistically significant differences (p<0.05). An effect size
between 0.2 and 0.4 was considered small, between 0.5 and
0.7 medium, and ≥0.8 as large [13]. Those OAB symptoms
that proved to be significantly associated with bladder diary
and filling cystometry parameters at a p value <0.10, were
entered into a linear multiple regression analysis, with the
bladder diary and cystometry items as dependent variables.
The factor age was also included in multiple regression
analysis. A subanalysis was performed on the data of wom-
en who also underwent a cystometry. As stated, none of
these women used anticholinergic drugs. All statistics were
performed using SPSS version 15.0.
Results
There were 3,280 bladder diaries and 2,153 filling cystome-
tries available for analysis. Ninety-five bladder diaries were
excluded, because the women did not report any LUTS. The
mean age of the studied population was 54.8 years
(±14.7 years) and 85.2% were parous women. The prevalence
of reported OAB symptoms in our study population is shown
in Table 1. The vast majority of women (92%) experienced
more than one bothersome lower urinary tract symptom. The
combination of bothersome urgency, frequency, and nocturia
was reported by 34.4% of women, and 26.2% of women
additionally experienced urgency incontinence.
The results of the univariate analysis (unpaired samples t
test) are shown in Tables 2 and 3. The presence of
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bothersome OAB symptoms showed a statistically signifi-
cant (p<0.05) association with almost all bladder diary and
filling cystometry parameters. If we consider an effect size
≥0.8 to be clinically relevant, the frequency symptom is best
associated with daytime frequency, the nocturia symptom
with nocturnal frequency, and the urgency incontinence
symptom with incontinence episodes. Bladder diary and
filling cystometry recorded filling volumes were significant-
ly smaller in women with bothersome OAB symptoms than
in women without bothersome OAB symptoms. The
strongest association regarding volume measurements and
OAB symptoms was found between frequency of voiding
and the mean voided volume. Although statistically signif-
icant associations were found for the urgency symptom, the
effect sizes were small, which may indicate little clinical
relevance. Subanalysis of bladder diaries that were complet-
ed by women without anticholinergic therapy did not alter
any of the results (data available on request).
The results of the multiple regression analysis are listed
in Table 4. After multivariate analysis for other OAB symp-
toms, the factor that was most strongly associated with
bladder diary daytime frequency was the frequency symp-
tom. The standardized β coefficients indicate that this effect
was two to five times higher than the effect of other OAB
symptoms. Frequency and nocturia are most strongly asso-
ciated with voided volumes recorded using the bladder diary
and filling cystometry. After multivariate analysis, urgency
and urgency incontinence symptoms were no longer
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Urge incontinence 1,929 (60.6)
Table 2 Mean outcomes with regard to bladder diary parameters for each OAB symptom
OAB symptom Bladder diary measures Group 1, mean (standard deviation) Group 2, mean (standard deviation) Cohen’s d
Frequency Daytime frequency episodes 7.2 (2.2) 9.4 (3.1) −0.82*
Nocturnal frequency episodes 0.8 (0.9) 1.4 (1.2) −0.59*
Incontinence episodes 2.3 (3.0) 3.6 (4.0) −0.37*
VOL minimum 114 (78) 85 (58) 0.42*
VOL mean 275 (108) 215 (88) 0.61*
VOL maximum 507 (205) 432 (187) 0.39*
Urgency Daytime frequency episodes 7.9 (2.5) 9.2 (3.2) −0.45*
Nocturnal frequency episodes 1 (1.0) 1.4 (1.2) −0.32*
Incontinence episodes 2.8 (3.3) 3.5 (4.0) −0.22*
VOL minimum 101 (70) 90 (63) 0.17*
VOL mean 253 (105) 222 (92) 0.32*
VOL maximum 486 (205) 436 (188) 0.26*
Nocturia Daytime frequency episodes 8.1 (2.7) 9.5 (3.2) −0.45*
Nocturnal frequency episodes 0.7 (0.8) 1.9 (1.3) −1.05*
Incontinence episodes 2.8 (3.2) 3.8 (4.3) −0.28*
VOL minimum 103 (72) 83 (57) 0.43*
VOL mean 256 (103) 205 (84) 0.55*
VOL maximum 492 (200) 409 (180) 0.44*
Urge incontinence Daytime frequency episodes 8.6 (3.1) 8.8 (3.0) −0.07**
Nocturnal frequency episodes 1.2 (1.2) 1.3 (1.2) −0.08*
Incontinence episodes 1.4 (2.6) 4.5 (3.9) −0.92*
VOL minimum 96 (71) 92 (62) 0.06**
VOL mean 241 (103) 227 (94) 0.14*
VOL maximum 462 (199) 447 (192) 0.07*
Group 1: women without symptoms, or symptoms that were not at all bothersome
Group 2: women with bothersome symptoms
VOL: volume in milliliters
*p<0.05
**p≥0.05 and <0.10
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significantly associated with most bladder diary and filling
cystometry parameters. Female age was evidently associat-
ed with nocturnal frequency episodes and volumes at first
and normal desire to void.
Discussion
The aim of the current study was to assess the association
between the OAB symptoms and objective parameters from
Table 3 Mean outcomes on filling cystometry parameters for each OAB symptom
OAB symptom Filling cystometry measures Group 1, mean (standard
deviation)




Frequency VOL first desire to void 235 (133) 196 (120) 0.31
VOL normal desire to void 332 (144) 275 (141) 0.40
VOL strong desire to void 495 (171) 412 (167) 0.49
VOL maximum cystometric
capacity
555 (171) 473 (168) 0.48
Urgency VOL first desire to void 229 (135) 195 (118) 0.27
VOL normal desire to void 320 (148) 275 (140) 0.31
VOL strong desire to void 467 (176) 417 (168) 0.29
VOL maximum cystometric
capacity
527 (176) 479 (168) 0.28
Nocturia VOL first desire to void 221 (127) 191 (120) 0.24
VOL normal desire to void 309 (148) 271 (137) 0.24
VOL strong desire to void 469 (173) 398 (163) 0.42
VOL maximum cystometric
capacity
534 (172) 455 (164) 0.47
Urge
incontinence
VOL first desire to void 213 (127) 202 (124) 0.09
VOL normal desire to void 306 (144) 281 (143) 0.17
VOL strong desire to void 457 (172) 421 (170) 0.21
VOL maximum cystometric
capacity
520 (171) 480 (171) 0.23
Group 1: women without symptom, or with symptoms that were not at all bothersome
Group 2: women with bothersome symptoms
VOL: volume in milliliters
*p<0.05
Table 4 Results of multiple regression analysis from bladder diary and filling cystometry parameters
Standardized β coefficients







IE FDV NDV SDV MCC
Frequency 0.27* 0.10* −0.17* −0.11* −0.20* 0.06* −0.09* −0.11* −0.14* −0.13*
Urgency 0.08* 0.02 0.01 −0.05* −0.03 −0.01 −0.08* −0.08* −0.05 −0.04
Nocturia 0.13* 0.40* −0.11* −0.17* −0.19 0.07 −0.11* −0.11* −0.16* −0.18*
Urge incontinence −0.05* −0.04 0.01 0.01 −0.01 0.37* −0.02 −0.05* −0.05* −0.06*
Age −0.05* 0.17* 0.05* 0.01 0.01 0.05* 0.18* 0.17* 0.07* 0.04
Correlation coefficient (Adjusted
R2)
0.13 * 0.26* 0.05* 0.06* 0.11* 0.17* 0.06* 0.07* 0.07* 0.08*
DF: daytime frequency, NF: nocturnal frequency, VOLmin: minimum voided volume, VOLmax: maximum voided volume, VOL mean: mean
voided volume, IE: incontinence episodes, FDV: volume at first desire to void, NDV: volume at normal desire to void, SDV: volume at strong desire
to void, MCC: volume at maximum cystometric capacity
*p<0.05
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a bladder diary and filling cystometry. Of all four OAB
symptoms the frequency symptom showed the strongest
association with daytime urinary frequency, nocturia with
nocturnal frequency, and urgency incontinence with incon-
tinence episodes as measured in the bladder diary. The
frequency and nocturia symptoms showed almost equal
and strong associations with bladder volumes as measured
in the bladder diary and by filling cystometry. The key
symptom of the OAB syndrome, urgency, was either not at
all or only poorly associated with objective parameters from
the bladder diary and filling cystometry.
The urgency symptom has been adopted as the key symp-
tom of the OAB syndrome. However, frequent day-time or
night-time micturition may be perceived by women as bother-
some, even in the absence of urgency [14, 15]. Furthermore,
studies about health-related quality of life in women with OAB
report that the presence of urgency alone is only associated with
a moderate degree of bother [16]. Ever since the introduction of
the OAB syndrome into official standardized terminology,
there has been an ongoing debate about the accuracy and
content of the definition of OAB. The emphasis on urgency
as the key symptom is not based on a scientific –factor and may
have originated from the introduction of the OAB syndrome by
the pharmaceutical industry [17, 18]. The urgency symptom is
notoriously difficult to define for both patient and expert.
Although the definition appears quite simple, it is suggested
that urgency might not be an “all or nothing” sensation. It is
plausible that there are different types of urgency that can be
experienced and modulated in various ways [19]. The individ-
ual perception of urgencymakes it almost impossible to create a
uniform definition for the heterogeneous patient population
with OAB symptoms. Because of the subjective nature of the
urgency symptom it is to be expected that associations with
objective parameters are limited. Our results support this view.
In many trials that evaluate the treatment of OAB, frequency
and incontinence episodes, and not urgency, are used as prima-
ry outcome measures [7–10]. Our results support the use of
frequency and incontinence episodes as outcome parameters in
OAB studies, since these symptoms show the best associations
between subjective and objective parameters.
It has also been previously demonstrated that the occurrence
of the OAB syndrome is associated with objective parameters
from the bladder diary and filling cystometry [20, 21]. How-
ever, these studies have not assessed which of the symptoms
contained in the official definition of the OAB syndrome are
responsible for this effect. Our results indicate that, after cor-
rection for the presence of other symptoms, the association
between OAB and objective parameters is mostly attributable
to the voiding frequency and nocturia. As stated, this may
reflect the difficulty in defining and quantifying urgency.
One limitation of the current study may be due to the
differences in the definition of urgency. The UDI definition
of urgency that we used is: “Do you experience a strong
feeling of urgency to empty your bladder?”. The current ICS
definition of urgency is: “Complaint of a sudden, compel-
ling desire to pass urine which is difficult to defer” [6].
These two definitions are not identical and therefore may
not be interchangeable. With respect to urgency inconti-
nence our definition is symptom-based. Therefore, we can-
not be sure that women with stress incontinence at
maximum cystometric capacity responded positively to the
urgency incontinence question.
Another possible limitation of our study is the fact that
the study population only consisted of women with urogen-
ital dysfunction. Consequently, the women without a partic-
ularly bothersome OAB symptom that were entered into the
comparison group (Group 1) were not entirely without
symptoms, but did experience other symptoms of urogenital
dysfunction. This may have limited the differences we ob-
served between groups. However, despite this, the observed
differences were not only statistically significant, but also
clinically relevant as shown by our effect size statistics. If
we had used a completely healthy control group, the differ-
ences were likely to have been even more pronounced.
Finally, we used a 48-h bladder diary, which is known to
be less accurate than a bladder diary that covers 3–7 days
[22]. However, it has been demonstrated that a prolonged
duration of bladder diary recording is associated with lower
compliance and higher burden for the patient [23, 24].
Conclusion
Daytime and nocturnal frequency symptoms are best associ-
ated with objective frequency and volume parameters from a
bladder diary and filling cystometry. In contrast, the urgency
symptom, which is essential in the current definition of OAB,
is poorly associated with these objective parameters. There-
fore, the current practice of using frequency and incontinence
episodes in the outcome research of OAB trials is justified.
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